TY - JOUR
T1 - Activation of the B-cell receptor successively activates NF-κB and STAT3 in chronic lymphocytic leukemia cells
AU - Rozovski, Uri
AU - Harris, David M.
AU - Li, Ping
AU - Liu, Zhiming
AU - Jain, Preetesh
AU - Veletic, Ivo
AU - Ferrajoli, Alessandra
AU - Burger, Jan
AU - Thompson, Philip
AU - Jain, Nitin
AU - Wierda, William
AU - Keating, Michael J.
AU - Estrov, Zeev
N1 - Publisher Copyright:
© 2017 UICC
PY - 2017/11/15
Y1 - 2017/11/15
N2 - In chronic lymphocytic leukemia (CLL) cells, both interleukin-6 (IL-6) and the B-cell receptor (BCR) activate Janus kinase 2 (JAK2) and induce the phosphorylation of signal transduction and activator of transcription 3 (STAT3) on tyrosine 705 residues. However, whereas IL-6 phosphorylates STAT3 within 15 min, stimulation of the BCR with anti-immunoglobulin M (IgM) antibodies phosphorylates STAT3 in 2–4 hr. Here, we show that this process takes longer because it requires transcriptional activity of NF-κB. Using an electromobility shift assay, we found that incubation with IgM antibodies for 4 or 18 hr, but not 15 min, increased NF-κB DNA-binding of CLL cells and increased binding was translated to increased transcriptional activity. Hence, 42% of the 83 NF-κB target genes were constitutively expressed in all CLL cells prior to any inducible stimuli. However, activation of the BCR increased the number of NF-κB target genes with detectable expression by 23%. Remarkably, prolonged incubation with anti-IgM antibodies induced a time-dependent transcription, production and secretion of IL-6 protein. The IgM-induced production of IL-6 prompted the phosphorylation of STAT3 on tyrosine residues. This effect was inhibited by the JAK1/2 inhibitor of the JAK/STAT3 pathway ruxolitinib. Taken together, these results suggest that in CLL cells, constitutive tonic activation of NF-κB can be further enhanced by the BCR and that the BCR-induced activation of the JAK/STAT3 pathway depends on the NF-κB induced production of IL-6.
AB - In chronic lymphocytic leukemia (CLL) cells, both interleukin-6 (IL-6) and the B-cell receptor (BCR) activate Janus kinase 2 (JAK2) and induce the phosphorylation of signal transduction and activator of transcription 3 (STAT3) on tyrosine 705 residues. However, whereas IL-6 phosphorylates STAT3 within 15 min, stimulation of the BCR with anti-immunoglobulin M (IgM) antibodies phosphorylates STAT3 in 2–4 hr. Here, we show that this process takes longer because it requires transcriptional activity of NF-κB. Using an electromobility shift assay, we found that incubation with IgM antibodies for 4 or 18 hr, but not 15 min, increased NF-κB DNA-binding of CLL cells and increased binding was translated to increased transcriptional activity. Hence, 42% of the 83 NF-κB target genes were constitutively expressed in all CLL cells prior to any inducible stimuli. However, activation of the BCR increased the number of NF-κB target genes with detectable expression by 23%. Remarkably, prolonged incubation with anti-IgM antibodies induced a time-dependent transcription, production and secretion of IL-6 protein. The IgM-induced production of IL-6 prompted the phosphorylation of STAT3 on tyrosine residues. This effect was inhibited by the JAK1/2 inhibitor of the JAK/STAT3 pathway ruxolitinib. Taken together, these results suggest that in CLL cells, constitutive tonic activation of NF-κB can be further enhanced by the BCR and that the BCR-induced activation of the JAK/STAT3 pathway depends on the NF-κB induced production of IL-6.
KW - chronic lymphocytic Leukemia
KW - nuclear factor κB
KW - phosphorylation
KW - signal transducer and activator of transcription 3
UR - http://www.scopus.com/inward/record.url?scp=85026730715&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85026730715&partnerID=8YFLogxK
U2 - 10.1002/ijc.30892
DO - 10.1002/ijc.30892
M3 - Article
C2 - 28722170
AN - SCOPUS:85026730715
SN - 0020-7136
VL - 141
SP - 2076
EP - 2081
JO - International journal of cancer
JF - International journal of cancer
IS - 10
ER -